"Development of the proteasome inhibitor Velcade (Bortezomib)" by Julian Adams, Ph.D., and Michael Kauffman, M.D., Ph.D.
Bold
Richard
R
D035843:Biomedical Research; D001897:Boronic Acids / Q000494:pharmacology* / Q000627:therapeutic use*; D000069286:Bortezomib; D002986:Clinical Trials as Topic; D015195:Drug Design; D004345:Drug Industry; D035082:Federal Government; D006801:Humans; D007373:Interinstitutional Relations; D009369:Neoplasms / Q000188:drug therapy; D011480:Protease Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D011719:Pyrazines / Q000494:pharmacology* / Q000627:therapeutic use*
D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib